Dietary treatment with Salmonella typhimurium expressing CCL22-targeting miRNA prevented the expression of CCL22 in vivo, resulting in differences in the severity of AD lesions, pruritus, serum levels of IL-4, and serum and skin tissue levels of CCL22 [203]. This evidence concerns the gene CCL22 and Alzheimer disease.